Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06944847 · ClinicalTrials.gov registry record · NA
Vaping and Smoking Project in People With Schizophrenia
A NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS), sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06944847: Recruiting NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS), sponsored by State University of New York at Buffalo.
NCT06944847 is a NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06944847, a NA study of Acute Abstinence From Cigarettes vs E-cigarettes (ENDS), is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the development of vaping cessation interventions amongst people with schizophrenia, the leading preventable cause of death in the US.
Primary Outcome
anger subscale score
Conditions Studied
Interventions
- BEHAVIORAL Acute (24-hour) abstinence
- BEHAVIORAL Ad libitum smoking/vaping
Study Locations (1)
New York
- University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-02-15 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
What NCT06944847 shows while recruiting
NCT06944847 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) appearing as the primary indexed condition, and to 2 interventions - of which Acute (24-hour) abstinence is the first listed.
NCT06944847 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06944847 about?
NCT06944847 is a clinical study titled "Vaping and Smoking Project in People With Schizophrenia". The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the...
What is the current status of trial NCT06944847?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2025-02-15. Estimated completion is 2027-04-01.
What conditions does trial NCT06944847 study?
This clinical trial studies the following conditions: Acute Abstinence From Cigarettes vs E-cigarettes (ENDS).
What interventions are being tested in trial NCT06944847?
The interventions under investigation include: Acute (24-hour) abstinence (BEHAVIORAL), Ad libitum smoking/vaping (BEHAVIORAL).
Who is sponsoring clinical trial NCT06944847?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06944847 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06944847's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI